These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Amino acid based prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents. Courtens C; Risseeuw M; Caljon G; Maes L; Martin A; Van Calenbergh S Bioorg Med Chem; 2019 Mar; 27(5):729-747. PubMed ID: 30692024 [TBL] [Abstract][Full Text] [Related]
5. Conformationally restrained aromatic analogues of fosmidomycin and FR900098. Kurz T; Schlüter K; Pein M; Behrendt C; Bergmann B; Walter RD Arch Pharm (Weinheim); 2007 Jul; 340(7):339-44. PubMed ID: 17611943 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimalarial activity of chain substituted pivaloyloxymethyl ester analogues of Fosmidomycin and FR900098. Kurz T; Schlüter K; Kaula U; Bergmann B; Walter RD; Geffken D Bioorg Med Chem; 2006 Aug; 14(15):5121-35. PubMed ID: 16679022 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of alpha-substituted fosmidomycin analogues as highly potent Plasmodium falciparum growth inhibitors. Haemers T; Wiesner J; Van Poecke S; Goeman J; Henschker D; Beck E; Jomaa H; Van Calenbergh S Bioorg Med Chem Lett; 2006 Apr; 16(7):1888-91. PubMed ID: 16439126 [TBL] [Abstract][Full Text] [Related]
8. Acyloxyalkyl ester prodrugs of FR900098 with improved in vivo anti-malarial activity. Ortmann R; Wiesner J; Reichenberg A; Henschker D; Beck E; Jomaa H; Schlitzer M Bioorg Med Chem Lett; 2003 Jul; 13(13):2163-6. PubMed ID: 12798327 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of alpha,beta-unsaturated alpha-aryl-substituted fosmidomycin analogues as DXR inhibitors. Devreux V; Wiesner J; Jomaa H; Van der Eycken J; Van Calenbergh S Bioorg Med Chem Lett; 2007 Sep; 17(17):4920-3. PubMed ID: 17583502 [TBL] [Abstract][Full Text] [Related]
10. gamma-Substituted bis(pivaloyloxymethyl)ester analogues of fosmidomycin and FR900098. Kurz T; Behrendt C; Pein M; Kaula U; Bergmann B; Walter RD Arch Pharm (Weinheim); 2007 Dec; 340(12):661-6. PubMed ID: 17994605 [TBL] [Abstract][Full Text] [Related]
11. Double prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents. Courtens C; Risseeuw M; Caljon G; Maes L; Cos P; Martin A; Van Calenbergh S Bioorg Med Chem Lett; 2019 May; 29(10):1232-1235. PubMed ID: 30879839 [TBL] [Abstract][Full Text] [Related]
12. Synthetic Fosmidomycin analogues with altered chelating moieties do not inhibit 1-deoxy-d-xylulose 5-phosphate Reductoisomerase or Plasmodium falciparum growth in vitro. Chofor R; Risseeuw MD; Pouyez J; Johny C; Wouters J; Dowd CS; Couch RD; Van Calenbergh S Molecules; 2014 Feb; 19(2):2571-87. PubMed ID: 24566322 [TBL] [Abstract][Full Text] [Related]
13. Phosphonodiamidate prodrugs of N-alkoxy analogs of a fosmidomycin surrogate as antimalarial and antitubercular agents. Courtens C; Risseeuw M; Caljon G; Cos P; Martin A; Van Calenbergh S Bioorg Med Chem Lett; 2019 May; 29(9):1051-1053. PubMed ID: 30857749 [TBL] [Abstract][Full Text] [Related]
14. Arylmethyl substituted derivatives of Fosmidomycin: synthesis and antimalarial activity. Schlüter K; Walter RD; Bergmann B; Kurz T Eur J Med Chem; 2006 Dec; 41(12):1385-97. PubMed ID: 17055117 [TBL] [Abstract][Full Text] [Related]
15. Divergent strategy for the synthesis of alpha-aryl-substituted fosmidomycin analogues. Devreux V; Wiesner J; Jomaa H; Rozenski J; Van der Eycken J; Van Calenbergh S J Org Chem; 2007 May; 72(10):3783-9. PubMed ID: 17428097 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and Antiplasmodial Activity of Novel Fosmidomycin Derivatives and Conjugates with Artemisinin and Aminochloroquinoline. Palla D; Antoniou AI; Baltas M; Menendez C; Grellier P; Mouray E; Athanassopoulos CM Molecules; 2020 Oct; 25(20):. PubMed ID: 33096817 [TBL] [Abstract][Full Text] [Related]
17. Fosmidomycin for the treatment of malaria. Wiesner J; Borrmann S; Jomaa H Parasitol Res; 2003 Jun; 90 Suppl 2():S71-6. PubMed ID: 12937969 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of beta- and gamma-oxa isosteres of fosmidomycin and FR900098 as antimalarial candidates. Haemers T; Wiesner J; Giessmann D; Verbrugghen T; Hillaert U; Ortmann R; Jomaa H; Link A; Schlitzer M; Van Calenbergh S Bioorg Med Chem; 2008 Mar; 16(6):3361-71. PubMed ID: 18158249 [TBL] [Abstract][Full Text] [Related]
19. Alkoxycarbonyloxyethyl ester prodrugs of FR900098 with improved in vivo antimalarial activity. Ortmann R; Wiesner J; Reichenberg A; Henschker D; Beck E; Jomaa H; Schlitzer M Arch Pharm (Weinheim); 2005 Jul; 338(7):305-14. PubMed ID: 15996004 [TBL] [Abstract][Full Text] [Related]
20. Resistance to the antimicrobial agent fosmidomycin and an FR900098 prodrug through mutations in the deoxyxylulose phosphate reductoisomerase gene (dxr). Armstrong CM; Meyers DJ; Imlay LS; Freel Meyers C; Odom AR Antimicrob Agents Chemother; 2015 Sep; 59(9):5511-9. PubMed ID: 26124156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]